Commission Business Editors STOCKHOLM, Sweden--(BUSINESS WIRE)--Jan. 31, 2001--The European Commission announced today that it has not approved SCA's acquisition of the Finnish company Metsa Tissue. This decision means that the agreement reached on 30 May 2000, through which SCA acquired a majority shareholding in Metsa Tissue from Metsa-Serla, will not be completed. According to the agreement, SCA was to pay EUR 295 M for 65% of the shares, corresponding to a debt-free payment for the entire company amounting to EUR 650 M. The agreement also listed the undertakings to divest certain operations that SCA was prepared to submit to the Commission, in the event that undertakings were necessary to obtain approval. It was furthermore prescribed that the seller would be entitled to compensation under certain circumstances, if the transaction could not be completed as a result of competition-related obstacles. However, this amount would be a maximum of SEK 150 M. As part of this matter, SCA submitted its commitments to divest businesses corresponding to some 75% of the acquired operations in Sweden, Norway and Denmark, including Swedish manufacturing units with a combined capacity amounting to approximately 100,000 tons. However, in addition to further concessions in Sweden and Denmark, the Commission demanded that SCA also divest operations in the consumer and AFH area in Finland as a prerequisite for its approval. The Commission's assessment is based on each Nordic country being considered a separate market for consumer and AFH tissue. A basic aim of the acquisition of Metsa Tissue was to substantially strengthen SCA's position in Finland and complement certain existing market positions in the other Nordic countries. For SCA, acceptance of the Commission's demands would be incompatible with this goal. The Commission's decision does not affect the terms and conditions of the other transactions for which agreement was reached between SCA and Metsa-Serla on May 30, 2000. These are SCA's sale of 50% of its shares in Modo Paper and SCA's acquisition of Metsa-Serla's European corrugated board operations. Neither does the decision affect SCA's existing minority stake in Metsa Tissue acquired prior to the agreement with Metsa-Serla. Stockholm 31 January 2001 SVENSKA CELLULOSA AKTIEBOLAGET SCA (publ) ------------------------------------------------------------ This information was brought to you by BIT http://www.bit.se The following files are available for download: http://www.bit.se/bitonline/2001/01/31/20010131BIT00630/bit0001.doc http://www.bit.se/bitonline/2001/01/31/20010131BIT00630/bit0002.pdf
SCA: Acquisition of Metsa Tissue Not Approved by European
Press spacebar to pause and continue. Press esc to stop.